CytomX Therapeutics CTMX
$ 1.09
0.0%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
DR. Sean McCarthy |
Employees in the company |
158 |
Shares |
73.8 M |
Market Cap[1] |
$ 80.5 M |
EBITDA (LTM) |
$ -53.6 M |
P/E (LTM) |
5.0 |
P/S (LTM) |
0.58 |
EPS (LTM) |
0.2 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.